Engineered Cytidine Deaminase Specificity for Base Editing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current base editing technologies face challenges in achieving precise genome editing, particularly in slowly dividing or post-mitotic cell populations, and are prone to off-target mutations due to the lack of specificity in cytosine deamination, which can lead to deleterious genetic side effects.
Innovation Solution
Engineered cytidine deaminase domains with altered target site preferences are developed, specifically modifying residues in recognition loops to enhance specificity for 2-3 nucleotide motifs, reducing off-target deamination by limiting the availability of cytosine substrates and incorporating mutations such as N57A/G, K60A/D, and Y130F to create more precise base editors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If base editors use cytidine deaminase domains to induce cytosine-to-thymidine transitions, then precise genome editing is achieved, but off-target mutations occur due to lack of specificity in cytosine deamination
Solution Approach 1:
The patent applies local quality by engineering cytidine deaminase domains with altered recognition loops that confer specificity for particular 2-3 nucleotide motifs. This means the deaminase only acts on cytosines within specific sequence contexts (e.g., TCG, TCA, TCC), rather than all cytosines, thereby maintaining editing precision while reducing off-target effects.
Solution Approach 2:
The patent changes the biochemical parameters of the cytidine deaminase by introducing mutations in recognition loops (such as N57A/G, K60A/D, Y130F) that alter substrate specificity. These parameter changes restrict the enzyme's activity to specific genomic contexts, resolving the contradiction between broad deamination capability and specific target recognition.
2Adaptability or versatility
If base editors are used in slowly dividing or post-mitotic cell populations, then genome editing is achieved, but HDR pathways are restricted making precise mutations difficult to create
Solution Approach 1:
The patent replaces the HDR-dependent mechanism (which requires cell division and is restricted to G2/S phases) with a base editing mechanism that directly converts cytosine to thymidine through deamination. This substitution eliminates the need for homologous recombination and cell proliferation, enabling precise editing in post-mitotic cells while maintaining editing precision.
3Manufacturing precision
If traditional nuclease-based genome editing technology is used, then genome editing is achieved, but competing non-homologous end-joining-mediated repair induces variable-length indel mutations
Solution Approach 1:
The patent converts the potential harm of DNA damage into a beneficial outcome by using base editing. Instead of creating double-strand breaks that trigger error-prone NHEJ repair (leading to indels), the base editor performs direct chemical conversion of cytosine to thymidine on single-stranded DNA, which is then fixed by high-fidelity replication. This transforms a harmful repair pathway into a beneficial precise editing mechanism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered base editors demonstrate significantly increased specificity for on-target motifs, reducing off-target mutations and enhancing the precision of genome editing, as shown by high-throughput sequencing data, with improved ratios of cognate to non-cognate editing events.
Implementation Method 1
Base Editors (BEs) that include a single strand nicking CRISPR-Cas9 (nCas9) protein fused to a cytidine deaminase domain and uracil glycosylase inhibitor (UGI) (BE3) efficiently induce cytidine-to-thymidine (C-to-T) base transitions
Data Source
AI summary
Methods and compositions for improving the genome-wide specificities of targeted base editing technologies.